Portal de Periódicos da CAPES

Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome

2014; Massachusetts Medical Society; Volume: 371; Issue: 2 Linguagem: Inglês

10.1056/nejmoa1313517

1533-4406

Richard S. Legro, Robert G. Brzyski, Michael P. Diamond, Christos Coutifaris, William D. Schlaff, Peter R. Casson, Gregory M. Christman, Hao Huang, Qingshang Yan, Ruben Alvero, Daniel J. Haisenleder, Kurt T. Barnhart, G. Wright Bates, Rebecca Usadi, Scott Lucidi, Valerie L. Baker, J.C. Trussell, Stephen A. Krawetz, Peter J. Snyder, Dana A. Ohl, Nanette Santoro, Esther Eisenberg, Heping Zhang,

Assisted Reproductive Technology and Twin Pregnancy

Clomiphene is the current first-line infertility treatment in women with the polycystic ovary syndrome, but aromatase inhibitors, including letrozole, might result in better pregnancy outcomes.